AVTherapeutics
About:
AVT develops cancer therapeutics and immunotherapeutic vaccines that can be used together with prevalent treatment modalities.
Website: http://avtherapeutics.com
Description:
AVT is primarily engaged in the business of developing Cancer Therapeutics and Immunotherapeutic Vaccines that can be used together with prevalent treatment modalities such as chemotherapy and radiation to treat active disease and to prevent metastases and recurrence.
Total Funding Amount:
$660000
Headquarters Location:
New York, New York, United States
Founded Date:
2011-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2013-12-31
IPO Status:
Private
Industries:
© 2025 bioDAO.ai